CEIRR will determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of respiratory viruses, including coronaviruses such as SARS-CoV-2, and characterize the immune response to infection to improve understanding of the immune correlates of protection and cross-protection. CEIRR will carry out a host of activities, including cohort studies and human and animal sampling to further understanding of infection, transmission and vaccination; identification of immunological factors that determine disease outcome in the response to infection and vaccination; and studies to determine how viruses evolve, adapt and transmit between humans and at interspecies interfaces.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-August-2021
Project End Date
14-September-2024
Budget Start Date
Budget End Date
Project Funding Information for 2023
Total Funding
$409,738
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Allergy and Infectious Diseases
$409,738
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 75N93021C00045-P00004-9999-2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 75N93021C00045-P00004-9999-2
Patents
No Patents information available for 75N93021C00045-P00004-9999-2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 75N93021C00045-P00004-9999-2
Clinical Studies
No Clinical Studies information available for 75N93021C00045-P00004-9999-2
News and More
Related News Releases
No news release information available for 75N93021C00045-P00004-9999-2
History
No Historical information available for 75N93021C00045-P00004-9999-2
Similar Projects
No Similar Projects information available for 75N93021C00045-P00004-9999-2